Durable Disease Control with Regorafenib in a Patient with Metastatic KIT-Mutated Colorectal Cancer

J Gastrointest Cancer. 2021 Jun;52(2):784-787. doi: 10.1007/s12029-020-00523-8. Epub 2020 Sep 18.

Authors

Jefferson Rios Pimenta¹, Douglas Jorge Racy², Luciana Mejia Zapata², Renata D'Alpino Peixoto^{3

4}

Affiliations

¹ Oncology Department, Hospital Alemão Oswaldo Cruz, Rua Treze de Maio, 1815 - Bela Vista, São Paulo, SP, 01327-001, Brazil.
² Radiology Department, Hospital Beneficência Portuguesa de São Paulo, São Paulo, Brazil.
³ Universidade Nove de Julho, São Paulo, Brazil. renatadalpino@gmail.com.
⁴ Centro Paulista de Oncologia-Grupo Oncoclínicas, São Paulo, Brazil. renatadalpino@gmail.com.

PMID: 32944848
DOI: 10.1007/s12029-020-00523-8

No abstract available

Publication types

Case Reports

MeSH terms

Colorectal Neoplasms / drug therapy*
Colorectal Neoplasms / metabolism
Colorectal Neoplasms / pathology
Disease-Free Survival
Humans
Male
Middle Aged
Mutation
Neoplasm Metastasis / drug therapy*
Neoplasm Metastasis / pathology
Phenylurea Compounds / therapeutic use*
Proto-Oncogene Proteins c-kit / metabolism
Pyridines / therapeutic use*

Substances

Phenylurea Compounds
Pyridines
regorafenib
KIT protein, human
Proto-Oncogene Proteins c-kit